CLH2_HUMAN - dbPTM
CLH2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CLH2_HUMAN
UniProt AC P53675
Protein Name Clathrin heavy chain 2
Gene Name CLTCL1
Organism Homo sapiens (Human).
Sequence Length 1640
Subcellular Localization Cytoplasmic vesicle membrane
Peripheral membrane protein
Cytoplasmic side. Membrane, coated pit
Peripheral membrane protein
Cytoplasmic side. Cytoplasmic face of coated pits and vesicles..
Protein Description Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-Golgi network (By similarity)..
Protein Sequence MAQILPVRFQEHFQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVTIIDMSDPMAPIRRPISAESAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMAEEVIFWKWVSVNTVALVTETAVYHWSMEGDSQPMKMFDRHTSLVGCQVIHYRTDEYQKWLLLVGISAQQNRVVGAMQLYSVDRKVSQPIEGHAAAFAEFKMEGNAKPATLFCFAVRNPTGGKLHIIEVGQPAAGNQPFVKKAVDVFFPPEAQNDFPVAMQIGAKHGVIYLITKYGYLHLYDLESGVCICMNRISADTIFVTAPHKPTSGIIGVNKKGQVLSVCVEEDNIVNYATNVLQNPDLGLRLAVRSNLAGAEKLFVRKFNTLFAQGSYAEAAKVAASAPKGILRTRETVQKFQSIPAQSGQASPLLQYFGILLDQGQLNKLESLELCHLVLQQGRKQLLEKWLKEDKLECSEELGDLVKTTDPMLALSVYLRANVPSKVIQCFAETGQFQKIVLYAKKVGYTPDWIFLLRGVMKISPEQGLQFSRMLVQDEEPLANISQIVDIFMENSLIQQCTSFLLDALKNNRPAEGLLQTWLLEMNLVHAPQVADAILGNKMFTHYDRAHIAQLCEKAGLLQQALEHYTDLYDIKRAVVHTHLLNPEWLVNFFGSLSVEDSVECLHAMLSANIRQNLQLCVQVASKYHEQLGTQALVELFESFKSYKGLFYFLGSIVNFSQDPDVHLKYIQAACKTGQIKEVERICRESSCYNPERVKNFLKEAKLTDQLPLIIVCDRFGFVHDLVLYLYRNNLQRYIEIYVQKVNPSRTPAVIGGLLDVDCSEEVIKHLIMAVRGQFSTDELVAEVEKRNRLKLLLPWLESQIQEGCEEPATHNALAKIYIDSNNSPECFLRENAYYDSSVVGRYCEKRDPHLACVAYERGQCDLELIKVCNENSLFKSEARYLVCRKDPELWAHVLEETNPSRRQLIDQVVQTALSETRDPEEISVTVKAFMTADLPNELIELLEKIVLDNSVFSEHRNLQNLLILTAIKADRTRVMEYISRLDNYDALDIASIAVSSALYEEAFTVFHKFDMNASAIQVLIEHIGNLDRAYEFAERCNEPAVWSQLAQAQLQKDLVKEAINSYIRGDDPSSYLEVVQSASRSNNWEDLVKFLQMARKKGRESYIETELIFALAKTSRVSELEDFINGPNNAHIQQVGDRCYEEGMYEAAKLLYSNVSNFARLASTLVHLGEYQAAVDNSRKASSTRTWKEVCFACMDGQEFRFAQLCGLHIVIHADELEELMCYYQDRGYFEELILLLEAALGLERAHMGMFTELAILYSKFKPQKMLEHLELFWSRVNIPKVLRAAEQAHLWAELVFLYDKYEEYDNAVLTMMSHPTEAWKEGQFKDIITKVANVELCYRALQFYLDYKPLLINDLLLVLSPRLDHTWTVSFFSKAGQLPLVKPYLRSVQSHNNKSVNEALNHLLTEEEDYQGLRASIDAYDNFDNISLAQQLEKHQLMEFRCIAAYLYKGNNWWAQSVELCKKDHLYKDAMQHAAESRDAELAQKLLQWFLEEGKRECFAACLFTCYDLLRPDMVLELAWRHNLVDLAMPYFIQVMREYLSKVDKLDALESLRKQEEHVTEPAPLVFDFDGHE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAQILPVRF
------CCCCCCCCH
19.20-
16UbiquitinationFQEHFQLQNLGINPA
HHHHHCHHCCCCCHH
32.1121963094
31PhosphorylationNIGFSTLTMESDKFI
HCCCEEEECCCCEEE
20.98-
34UbiquitinationFSTLTMESDKFICIR
CEEEECCCCEEEEEE
34.9721963094
67PhosphorylationAPIRRPISAESAIMN
CCCCCCCCHHHHHCC
28.77-
78AcetylationAIMNPASKVIALKAG
HHCCCCHHEEEHHCC
39.5026051181
78UbiquitinationAIMNPASKVIALKAG
HHCCCCHHEEEHHCC
39.5022817900
83AcetylationASKVIALKAGKTLQI
CHHEEEHHCCCEEEE
46.1825953088
83UbiquitinationASKVIALKAGKTLQI
CHHEEEHHCCCEEEE
46.1827667366
86UbiquitinationVIALKAGKTLQIFNI
EEEHHCCCEEEEEEE
51.4222817900
86 (in isoform 1)Ubiquitination-51.4221890473
86 (in isoform 2)Ubiquitination-51.4221890473
95SulfoxidationLQIFNIEMKSKMKAH
EEEEEEECCHHHCCC
5.4121406390
96AcetylationQIFNIEMKSKMKAHT
EEEEEECCHHHCCCC
33.8526051181
96NeddylationQIFNIEMKSKMKAHT
EEEEEECCHHHCCCC
33.8532015554
96UbiquitinationQIFNIEMKSKMKAHT
EEEEEECCHHHCCCC
33.8522817900
96 (in isoform 1)Ubiquitination-33.8521890473
96 (in isoform 2)Ubiquitination-33.8521890473
98UbiquitinationFNIEMKSKMKAHTMA
EEEECCHHHCCCCCH
38.6122817900
100UbiquitinationIEMKSKMKAHTMAEE
EECCHHHCCCCCHHH
40.5322817900
103PhosphorylationKSKMKAHTMAEEVIF
CHHHCCCCCHHHHHH
23.9617081983
115PhosphorylationVIFWKWVSVNTVALV
HHHHEECCCCCEEEE
14.4524425749
134UbiquitinationVYHWSMEGDSQPMKM
EHHHHCCCCCCCCCC
31.0921963094
139UbiquitinationMEGDSQPMKMFDRHT
CCCCCCCCCCCCCCC
3.6822817900
161UbiquitinationIHYRTDEYQKWLLLV
EEEECHHHHHHHHHH
20.4327667366
171PhosphorylationWLLLVGISAQQNRVV
HHHHHCCCCCCCCCE
17.69-
181SulfoxidationQNRVVGAMQLYSVDR
CCCCEEEEEEEECCC
2.0228183972
184PhosphorylationVVGAMQLYSVDRKVS
CEEEEEEEECCCCCC
6.9728152594
185PhosphorylationVGAMQLYSVDRKVSQ
EEEEEEEECCCCCCC
26.5728152594
189UbiquitinationQLYSVDRKVSQPIEG
EEEECCCCCCCCCCC
41.6022505724
191PhosphorylationYSVDRKVSQPIEGHA
EECCCCCCCCCCCCH
33.02-
203UbiquitinationGHAAAFAEFKMEGNA
CCHHHHHEEECCCCC
39.0723000965
214PhosphorylationEGNAKPATLFCFAVR
CCCCCCEEEEEEEEE
28.97-
224PhosphorylationCFAVRNPTGGKLHII
EEEEECCCCCCEEEE
63.21-
227UbiquitinationVRNPTGGKLHIIEVG
EECCCCCCEEEEEEC
37.9329967540
245UbiquitinationAGNQPFVKKAVDVFF
CCCCCCCCEEEEEEC
35.0821963094
246UbiquitinationGNQPFVKKAVDVFFP
CCCCCCCEEEEEECC
48.6322817900
248UbiquitinationQPFVKKAVDVFFPPE
CCCCCEEEEEECCHH
9.9023000965
253UbiquitinationKAVDVFFPPEAQNDF
EEEEEECCHHHCCCC
17.8523000965
308UbiquitinationDTIFVTAPHKPTSGI
CEEEEECCCCCCCCE
27.0323000965
329UbiquitinationGQVLSVCVEEDNIVN
CCEEEEEECCCCHHH
9.4021963094
338UbiquitinationEDNIVNYATNVLQNP
CCCHHHHHHHHHHCC
6.3621963094
362UbiquitinationSNLAGAEKLFVRKFN
CCCCCHHHHHHHHHH
46.8429967540
367UbiquitinationAEKLFVRKFNTLFAQ
HHHHHHHHHHHHHHC
37.3529967540
377PhosphorylationTLFAQGSYAEAAKVA
HHHHCCCHHHHHHHH
18.4523532336
386PhosphorylationEAAKVAASAPKGILR
HHHHHHHCCCCCEEC
35.0522210691
389UbiquitinationKVAASAPKGILRTRE
HHHHCCCCCEECCHH
59.3029967540
394PhosphorylationAPKGILRTRETVQKF
CCCCEECCHHHHHHH
29.4320068231
394 (in isoform 2)Phosphorylation-29.43-
397PhosphorylationGILRTRETVQKFQSI
CEECCHHHHHHHHCC
25.5820068231
407UbiquitinationKFQSIPAQSGQASPL
HHHCCCCCCCCCCHH
42.6222817900
412UbiquitinationPAQSGQASPLLQYFG
CCCCCCCCHHHHHHH
14.2721890473
415UbiquitinationSGQASPLLQYFGILL
CCCCCHHHHHHHHCC
4.3821963094
418UbiquitinationASPLLQYFGILLDQG
CCHHHHHHHHCCCCC
2.9422817900
431UbiquitinationQGQLNKLESLELCHL
CCCCHHHHHHHHHHH
55.6923000965
445UbiquitinationLVLQQGRKQLLEKWL
HHHHHHHHHHHHHHH
52.7222817900
450AcetylationGRKQLLEKWLKEDKL
HHHHHHHHHHHHCCC
58.7723236377
450MalonylationGRKQLLEKWLKEDKL
HHHHHHHHHHHHCCC
58.7726320211
450UbiquitinationGRKQLLEKWLKEDKL
HHHHHHHHHHHHCCC
58.7721890473
450 (in isoform 1)Ubiquitination-58.7721890473
450 (in isoform 2)Ubiquitination-58.7721890473
453AcetylationQLLEKWLKEDKLECS
HHHHHHHHHCCCHHH
63.8525953088
453MalonylationQLLEKWLKEDKLECS
HHHHHHHHHCCCHHH
63.8526320211
453UbiquitinationQLLEKWLKEDKLECS
HHHHHHHHHCCCHHH
63.8527667366
453 (in isoform 1)Ubiquitination-63.8521890473
453 (in isoform 2)Ubiquitination-63.8521890473
456AcetylationEKWLKEDKLECSEEL
HHHHHHCCCHHHHHH
47.4826822725
456UbiquitinationEKWLKEDKLECSEEL
HHHHHHCCCHHHHHH
47.4822817900
468UbiquitinationEELGDLVKTTDPMLA
HHHHHHHHCCCCHHH
53.6723000965
469UbiquitinationELGDLVKTTDPMLAL
HHHHHHHCCCCHHHH
29.0223000965
477PhosphorylationTDPMLALSVYLRANV
CCCHHHHHHHHHCCC
11.7821406692
479PhosphorylationPMLALSVYLRANVPS
CHHHHHHHHHCCCCH
6.2621406692
506AcetylationQKIVLYAKKVGYTPD
EEEEEHHHHHCCCCH
34.1426051181
506MalonylationQKIVLYAKKVGYTPD
EEEEEHHHHHCCCCH
34.1426320211
506UbiquitinationQKIVLYAKKVGYTPD
EEEEEHHHHHCCCCH
34.1423000965
507AcetylationKIVLYAKKVGYTPDW
EEEEHHHHHCCCCHH
32.4923236377
507UbiquitinationKIVLYAKKVGYTPDW
EEEEHHHHHCCCCHH
32.4923000965
507 (in isoform 1)Ubiquitination-32.4921890473
507 (in isoform 2)Ubiquitination-32.4921890473
510PhosphorylationLYAKKVGYTPDWIFL
EHHHHHCCCCHHHHH
20.34-
576UbiquitinationALKNNRPAEGLLQTW
HHHCCCCCHHHHHHH
21.9121963094
581UbiquitinationRPAEGLLQTWLLEMN
CCCHHHHHHHHHHCC
35.3621963094
599UbiquitinationAPQVADAILGNKMFT
HHHHHHHHHCCCCCC
5.3521963094
619UbiquitinationHIAQLCEKAGLLQQA
HHHHHHHHHCHHHHH
46.9221963094
634PhosphorylationLEHYTDLYDIKRAVV
HHHCCCHHHHHHHHH
20.59-
637AcetylationYTDLYDIKRAVVHTH
CCCHHHHHHHHHHHH
31.2626051181
637UbiquitinationYTDLYDIKRAVVHTH
CCCHHHHHHHHHHHH
31.2621963094
651UbiquitinationHLLNPEWLVNFFGSL
HCCCHHHHHHHHCCC
1.8421963094
672PhosphorylationECLHAMLSANIRQNL
HHHHHHHCCHHHHHH
13.2420068231
699UbiquitinationQLGTQALVELFESFK
HHHHHHHHHHHHHHC
7.2321963094
704UbiquitinationALVELFESFKSYKGL
HHHHHHHHHCCCCHH
30.5522817900
726UbiquitinationVNFSQDPDVHLKYIQ
HCCCCCCHHHHHHHH
49.0827667366
731PhosphorylationDPDVHLKYIQAACKT
CCHHHHHHHHHHHHC
12.4828152594
737AcetylationKYIQAACKTGQIKEV
HHHHHHHHCCCHHHH
51.4625953088
737MalonylationKYIQAACKTGQIKEV
HHHHHHHHCCCHHHH
51.4626320211
737SuccinylationKYIQAACKTGQIKEV
HHHHHHHHCCCHHHH
51.46-
737SuccinylationKYIQAACKTGQIKEV
HHHHHHHHCCCHHHH
51.4627452117
737UbiquitinationKYIQAACKTGQIKEV
HHHHHHHHCCCHHHH
51.4621963094
742AcetylationACKTGQIKEVERICR
HHHCCCHHHHHHHHH
48.0623749302
742UbiquitinationACKTGQIKEVERICR
HHHCCCHHHHHHHHH
48.0621906983
742 (in isoform 1)Ubiquitination-48.0621890473
742 (in isoform 2)Ubiquitination-48.0621890473
744UbiquitinationKTGQIKEVERICRES
HCCCHHHHHHHHHHC
5.2121890473
751PhosphorylationVERICRESSCYNPER
HHHHHHHCCCCCHHH
13.3222617229
752PhosphorylationERICRESSCYNPERV
HHHHHHCCCCCHHHH
18.8322617229
754PhosphorylationICRESSCYNPERVKN
HHHHCCCCCHHHHHH
35.3830619164
760UbiquitinationCYNPERVKNFLKEAK
CCCHHHHHHHHHHCC
48.48-
764AcetylationERVKNFLKEAKLTDQ
HHHHHHHHHCCCCCC
52.0325953088
764MalonylationERVKNFLKEAKLTDQ
HHHHHHHHHCCCCCC
52.0326320211
764UbiquitinationERVKNFLKEAKLTDQ
HHHHHHHHHCCCCCC
52.0327667366
768UbiquitinationNFLKEAKLTDQLPLI
HHHHHCCCCCCCCEE
9.1023000965
784UbiquitinationVCDRFGFVHDLVLYL
EECCCCCHHHHHHHH
3.3422817900
789UbiquitinationGFVHDLVLYLYRNNL
CCHHHHHHHHHHCCH
2.9522817900
794UbiquitinationLVLYLYRNNLQRYIE
HHHHHHHCCHHHHHE
39.7521963094
799PhosphorylationYRNNLQRYIEIYVQK
HHCCHHHHHEEEEEE
7.02-
803PhosphorylationLQRYIEIYVQKVNPS
HHHHHEEEEEECCCC
5.52-
806UbiquitinationYIEIYVQKVNPSRTP
HHEEEEEECCCCCCC
33.6630230243
806 (in isoform 1)Ubiquitination-33.6621890473
806 (in isoform 2)Ubiquitination-33.6621890473
813UbiquitinationKVNPSRTPAVIGGLL
ECCCCCCCCEECCEE
24.3423000965
818UbiquitinationRTPAVIGGLLDVDCS
CCCCEECCEECCCCC
16.3723000965
841PhosphorylationMAVRGQFSTDELVAE
HHHHCCCCHHHHHHH
27.36-
842PhosphorylationAVRGQFSTDELVAEV
HHHCCCCHHHHHHHH
34.48-
846UbiquitinationQFSTDELVAEVEKRN
CCCHHHHHHHHHHHC
3.9221890473
851AcetylationELVAEVEKRNRLKLL
HHHHHHHHHCHHHHH
61.2123236377
851UbiquitinationELVAEVEKRNRLKLL
HHHHHHHHHCHHHHH
61.2123000965
856AcetylationVEKRNRLKLLLPWLE
HHHHCHHHHHHHHHH
33.5726051181
856UbiquitinationVEKRNRLKLLLPWLE
HHHHCHHHHHHHHHH
33.5723000965
873UbiquitinationIQEGCEEPATHNALA
HHHCCCCCCHHCCEE
21.8423000965
881AcetylationATHNALAKIYIDSNN
CHHCCEEEEEECCCC
36.5726051181
883PhosphorylationHNALAKIYIDSNNSP
HCCEEEEEECCCCCC
9.6622817900
889PhosphorylationIYIDSNNSPECFLRE
EEECCCCCCCEECCC
26.7321815630
894UbiquitinationNNSPECFLRENAYYD
CCCCCEECCCCCCCC
11.5321963094
899PhosphorylationCFLRENAYYDSSVVG
EECCCCCCCCHHHHH
21.2727642862
900PhosphorylationFLRENAYYDSSVVGR
ECCCCCCCCHHHHHH
13.6227642862
903UbiquitinationENAYYDSSVVGRYCE
CCCCCCHHHHHHHHC
20.2321963094
911UbiquitinationVVGRYCEKRDPHLAC
HHHHHHCCCCCCEEE
59.5523000965
921PhosphorylationPHLACVAYERGQCDL
CCEEEEEECCCCCCH
5.9328152594
932UbiquitinationQCDLELIKVCNENSL
CCCHHHHHHCCCCCC
54.0521963094
938PhosphorylationIKVCNENSLFKSEAR
HHHCCCCCCCCHHHH
29.0724719451
941UbiquitinationCNENSLFKSEARYLV
CCCCCCCCHHHHHHE
53.3221963094
951UbiquitinationARYLVCRKDPELWAH
HHHHEECCCHHHHHH
72.9429967540
959UbiquitinationDPELWAHVLEETNPS
CHHHHHHHHHHCCHH
5.7821963094
963PhosphorylationWAHVLEETNPSRRQL
HHHHHHHCCHHHHHH
42.9527251275
966PhosphorylationVLEETNPSRRQLIDQ
HHHHCCHHHHHHHHH
42.0127251275
989PhosphorylationTRDPEEISVTVKAFM
CCCHHHEEEEEEEHH
18.2721406692
991PhosphorylationDPEEISVTVKAFMTA
CHHHEEEEEEEHHHC
14.9721406692
996SulfoxidationSVTVKAFMTADLPNE
EEEEEEHHHCCCCHH
3.4528183972
996UbiquitinationSVTVKAFMTADLPNE
EEEEEEHHHCCCCHH
3.4523000965
1016PhosphorylationEKIVLDNSVFSEHRN
HHHHCCCCCCCCCCC
24.9820068231
1019PhosphorylationVLDNSVFSEHRNLQN
HCCCCCCCCCCCHHH
30.2720068231
1034AcetylationLLILTAIKADRTRVM
HHHHHHHHCCHHHHH
41.5925953088
1034UbiquitinationLLILTAIKADRTRVM
HHHHHHHHCCHHHHH
41.5923000965
1034 (in isoform 1)Ubiquitination-41.5921890473
1034 (in isoform 2)Ubiquitination-41.5921890473
1038PhosphorylationTAIKADRTRVMEYIS
HHHHCCHHHHHHHHH
28.32-
1043PhosphorylationDRTRVMEYISRLDNY
CHHHHHHHHHCCCCC
6.0123403867
1045PhosphorylationTRVMEYISRLDNYDA
HHHHHHHHCCCCCCH
26.37-
1096PhosphorylationIGNLDRAYEFAERCN
HCCHHHHHHHHHHCC
16.6928152594
1122UbiquitinationQLQKDLVKEAINSYI
HHHHHHHHHHHHHHH
49.0429967540
1141UbiquitinationPSSYLEVVQSASRSN
HHHHHHHHHHHCCCC
2.4421963094
1167PhosphorylationARKKGRESYIETELI
HHHCCCHHHHHHHHH
30.0128857561
1168PhosphorylationRKKGRESYIETELIF
HHCCCHHHHHHHHHH
9.6820068231
1168 (in isoform 2)Phosphorylation-9.68-
1171PhosphorylationGRESYIETELIFALA
CCHHHHHHHHHHHHH
26.9123898821
1171 (in isoform 2)Phosphorylation-26.91-
1179UbiquitinationELIFALAKTSRVSEL
HHHHHHHHCCCHHHH
48.1321963094
1181PhosphorylationIFALAKTSRVSELED
HHHHHHCCCHHHHHH
29.94-
1206PhosphorylationQQVGDRCYEEGMYEA
HHHHHHHHHHCHHHH
20.22-
1211PhosphorylationRCYEEGMYEAAKLLY
HHHHHCHHHHHHHHH
17.1727642862
1216UbiquitinationGMYEAAKLLYSNVSN
CHHHHHHHHHHCHHH
4.6821963094
1229PhosphorylationSNFARLASTLVHLGE
HHHHHHHHHHHHHHH
27.19-
1254UbiquitinationASSTRTWKEVCFACM
CCCCCCHHHHHHHCC
39.3921963094
1275UbiquitinationFAQLCGLHIVIHADE
HHHHHCCEEEEEHHH
9.5021890473
1309UbiquitinationLLEAALGLERAHMGM
HHHHHHCCCHHHHCH
4.1321890473
1314SulfoxidationLGLERAHMGMFTELA
HCCCHHHHCHHHHHH
3.9828183972
1315UbiquitinationGLERAHMGMFTELAI
CCCHHHHCHHHHHHH
9.7422817900
1316SulfoxidationLERAHMGMFTELAIL
CCHHHHCHHHHHHHH
2.6728183972
1318PhosphorylationRAHMGMFTELAILYS
HHHHCHHHHHHHHHH
22.6124117733
1320UbiquitinationHMGMFTELAILYSKF
HHCHHHHHHHHHHCC
3.0522817900
1324PhosphorylationFTELAILYSKFKPQK
HHHHHHHHHCCCHHH
12.0524117733
1325PhosphorylationTELAILYSKFKPQKM
HHHHHHHHCCCHHHH
28.3324117733
1325UbiquitinationTELAILYSKFKPQKM
HHHHHHHHCCCHHHH
28.3321963094
1341PhosphorylationEHLELFWSRVNIPKV
HHHHHHHHHCCHHHH
21.0130108239
1347AcetylationWSRVNIPKVLRAAEQ
HHHCCHHHHHHHHHH
50.5326051181
1347MalonylationWSRVNIPKVLRAAEQ
HHHCCHHHHHHHHHH
50.5326320211
1347UbiquitinationWSRVNIPKVLRAAEQ
HHHCCHHHHHHHHHH
50.5327667366
1347 (in isoform 1)Ubiquitination-50.5321890473
1347 (in isoform 2)Ubiquitination-50.5321890473
1349UbiquitinationRVNIPKVLRAAEQAH
HCCHHHHHHHHHHHH
3.7322817900
1354UbiquitinationKVLRAAEQAHLWAEL
HHHHHHHHHHHHHHH
29.3822817900
1359UbiquitinationAEQAHLWAELVFLYD
HHHHHHHHHHHHHHH
13.4521963094
1377UbiquitinationEYDNAVLTMMSHPTE
HHCCCHHHHCCCCHH
12.2921890473
1387UbiquitinationSHPTEAWKEGQFKDI
CCCHHHHHCCCHHHH
60.0422817900
1392AcetylationAWKEGQFKDIITKVA
HHHCCCHHHHHHHHH
39.8825953088
1392SuccinylationAWKEGQFKDIITKVA
HHHCCCHHHHHHHHH
39.8823954790
1392UbiquitinationAWKEGQFKDIITKVA
HHHCCCHHHHHHHHH
39.8827667366
1392 (in isoform 1)Ubiquitination-39.8821890473
1392 (in isoform 2)Ubiquitination-39.8821890473
1396PhosphorylationGQFKDIITKVANVEL
CCHHHHHHHHHCHHH
21.57-
1397UbiquitinationQFKDIITKVANVELC
CHHHHHHHHHCHHHH
29.0121963094
1411UbiquitinationCYRALQFYLDYKPLL
HHHHHHHHHCCHHHH
5.9121890473
1441AcetylationWTVSFFSKAGQLPLV
EEEEEECCCCCCCCC
51.91-
1441SuccinylationWTVSFFSKAGQLPLV
EEEEEECCCCCCCCC
51.91-
1441SuccinylationWTVSFFSKAGQLPLV
EEEEEECCCCCCCCC
51.91-
1449AcetylationAGQLPLVKPYLRSVQ
CCCCCCCHHHHHHHH
35.3119608861
1449UbiquitinationAGQLPLVKPYLRSVQ
CCCCCCCHHHHHHHH
35.3121963094
1451PhosphorylationQLPLVKPYLRSVQSH
CCCCCHHHHHHHHHC
14.7228152594
1461UbiquitinationSVQSHNNKSVNEALN
HHHHCCCCCHHHHHH
62.1829967540
1462PhosphorylationVQSHNNKSVNEALNH
HHHCCCCCHHHHHHH
32.0917081983
1462 (in isoform 2)Phosphorylation-32.09-
1468UbiquitinationKSVNEALNHLLTEEE
CCHHHHHHHHCCCCC
30.7021963094
1477PhosphorylationLLTEEEDYQGLRASI
HCCCCCHHCHHHHHC
14.0427642862
1487PhosphorylationLRASIDAYDNFDNIS
HHHHCHHHCCCCCCH
13.99-
1490UbiquitinationSIDAYDNFDNISLAQ
HCHHHCCCCCCHHHH
7.5121963094
1494PhosphorylationYDNFDNISLAQQLEK
HCCCCCCHHHHHHHH
24.73-
1501AcetylationSLAQQLEKHQLMEFR
HHHHHHHHHCCHHHH
45.29-
1505UbiquitinationQLEKHQLMEFRCIAA
HHHHHCCHHHHHHHH
3.5321963094
1524UbiquitinationGNNWWAQSVELCKKD
CCCEEHHHHHHHHCC
15.1521963094
1529AcetylationAQSVELCKKDHLYKD
HHHHHHHHCCCHHHH
74.0825953088
1529UbiquitinationAQSVELCKKDHLYKD
HHHHHHHHCCCHHHH
74.0832015554
1535UbiquitinationCKKDHLYKDAMQHAA
HHCCCHHHHHHHHHH
45.4229967540
1555UbiquitinationELAQKLLQWFLEEGK
HHHHHHHHHHHHHCH
39.0329967540
1562UbiquitinationQWFLEEGKRECFAAC
HHHHHHCHHHHHHHH
48.5921963094
1564UbiquitinationFLEEGKRECFAACLF
HHHHCHHHHHHHHHH
37.1629967540
1612UbiquitinationEYLSKVDKLDALESL
HHHHCCHHHHHHHHH
51.7829967540
1618PhosphorylationDKLDALESLRKQEEH
HHHHHHHHHHHHHCC
34.0319413330
1621UbiquitinationDALESLRKQEEHVTE
HHHHHHHHHHCCCCC
68.3129967540

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CLH2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CLH2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CLH2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SNX5_HUMANSNX5physical
15133132
AHSA1_HUMANAHSA1physical
26344197
AT1A1_HUMANATP1A1physical
26344197
TCPW_HUMANCCT6Bphysical
26344197
SYEP_HUMANEPRSphysical
26344197
IDH3A_HUMANIDH3Aphysical
26344197
2AAA_HUMANPPP2R1Aphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CLH2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-450; LYS-764 AND LYS-1449,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1096, AND MASSSPECTROMETRY.

TOP